You are here

oncologists

Oncologists Defend CAR-T After FDA Advisory

BioSpace

Mon, 12/18/23 - 10:11 am

Docs who take pharma dollars more likely to prescribe inappropriate drugs: study

Fierce Pharma

Fri, 10/27/23 - 11:45 am

physician payments

Oncology Practices May Be Hurt by Medicare Drug Price Negotiations

OBR Oncology

Thu, 10/12/23 - 05:29 pm

ASCO in Review: Oncologists See Practice-Changing, Affirming Data

BioSpace

Thu, 06/8/23 - 09:26 pm

non-small cell lung cancer

Moderna Therapeutics

8 Striking Facts about Biopharma Digital Ads

Zoom Rx

Tue, 08/30/22 - 11:46 am

Oncologists on board for Novartis' prostate cancer radiotherapy, but logistics could hit uptake: survey

Fierce Pharma

Wed, 02/23/22 - 10:29 am

prostate cancer

Pharma reps need to bone up on scientific data and real-world evidence for oncology discussions: study

Endpoints

Tue, 01/25/22 - 11:34 pm

real world evidence

Oncologists Were Paid To Prescribe Generic Chemotherapy (Here’s Why It Didn’t Change A Thing)

Forbes

Thu, 08/27/20 - 10:52 am

UnitedHealthcare

physician payments

Sales rep tips for oncologist calls: Keep it short, use visuals and bring new info, says consultancy

Fierce Pharma

Fri, 02/7/20 - 10:55 am

Docs are excited about CAR-T, BTK drugs, survey finds. How can pharma best promote them?

Fierce Pharma

Tue, 01/7/20 - 11:11 pm

Multiple Myeloma

All hail drug reps: Most cancer docs rely on pharma salespeople for info, survey finds

Fierce Pharma

Tue, 12/17/19 - 10:47 am

Cardinal Health

Oncologists listen when the FDA speaks, even after a drug hits the market

Endpoints

Thu, 09/26/19 - 10:47 am

Standardization Of Drug Compendia That Support Off-Label Use Reimbursement Of Cancer Drugs

Forbes

Wed, 10/10/18 - 10:27 am

Financial disclosure lacking in publication of clinical trials, study finds

Science Daily

Fri, 08/31/18 - 10:35 am

physician payments

scientific journals

FDA warns of decreased survival in 2 studies of Keytruda, Tecentriq

Biopharma Dive

Mon, 05/21/18 - 09:44 pm

clinical trials

Oncologists' pricing pushback mounts as docs snub costly me-too drugs

Fierce Pharma

Fri, 10/9/15 - 10:10 am

Sandoz gets ready to make the biosimilar case with oncologists

Medical Marketing and Media

Thu, 01/22/15 - 09:51 am

Seeking Oncologists' Attention — More Ads, Fewer Reps

Medscape

Tue, 08/20/13 - 09:21 am

Oncologists Continue To Shun Sales Reps More Than Other Docs

Pharmalot

Mon, 08/12/13 - 11:11 am

Survey: Many docs will be slow to switch to biosimilar mAbs

Fierce Biotech

Mon, 10/29/12 - 11:42 am

Pages